Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$9.6M
+10.8% from 2023
Prescriptions
1,848
$5,185.70 per claim
Patients
393
236 prescribers
Total spending, 2024
$9.6M
$24,384.68 per patient
Medicare prescription drug plans paid $9.6M for Zirabev in 2024, for 1,848 prescriptions and refills to 393 patients (up 10.8% from 2023). The average cost per claim was $5,185.70.
California had the highest Medicare cost for Zirabev in 2024: $2.6M for 523 claims, followed by New York ($1.6M).
Azriel Hirschfeld, hematology-oncology in Brooklyn, NY, had the highest Medicare cost for Zirabev in 2024: 68 claims costing $576K.
Zirabev is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Azriel Hirschfeld Brooklyn, NY | Hematology-Oncology | 68 | 22 | $576K |
| Nader Javadi Calabasas, CA | Hematology-Oncology | 41 | Under 11 | $253K |
| Sejal N Vaidya |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 141 | 1,263 | 240 | $7.0M |
| 2023 | 191 | 1,702 | 315 | $8.7M |
| 2024 | 236 | 1,848 | 393 | $9.6M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 49 |
| 21 |
| $204K |
| Brittany Gehm Denville, NJ | Nurse Practitioner | 16 | Under 11 | $174K |
| Dirk C Davidson Crossville, TN | Medical Oncology | 27 | Under 11 | $171K |
| Joseph P Yoe New York, NY | Hematology-Oncology | 30 | Under 11 | $156K |
| Arjun Iyengar New York, NY | Hematology-Oncology | 25 | Under 11 | $154K |
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 33 | Under 11 | $134K |
| David P Ellent Kingwood, TX | Hematology-Oncology | 13 | Under 11 | $132K |
| Babak Baseri Cerritos, CA | Hematology-Oncology | 22 | Under 11 | $129K |
| Virginia I Stark-Vance Dallas, TX | Hematology-Oncology | 13 | Under 11 | $127K |
| Trina Poretta Voorhees, NJ | Hematology-Oncology | 30 | Under 11 | $123K |
| Maria A Scouros Houston, TX | Hematology-Oncology | 16 | Under 11 | $118K |
| Ravi K Patel Stuart, FL | Hematology-Oncology | 21 | Under 11 | $116K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 30 | Under 11 | $113K |
| Juan A Cattoni III Reno, NV | Hematology-Oncology | 13 | Under 11 | $112K |
| Mustafa G Boxwala Farmington Hills, MI | Medical Oncology | 16 | Under 11 | $111K |
| Jen Chin Wang Long Beach, NY | Internal Medicine | 15 | Under 11 | $109K |
| Phu N Tran Port St Lucie, FL | Hematology-Oncology | 26 | Under 11 | $105K |
| Vaibhav Verma Canfield, OH | Internal Medicine | 26 | Under 11 | $105K |
| Bertrand Y Tuan San Francisco, CA | Hematology-Oncology | 28 | Under 11 | $104K |
| Amit A Patel Jersey City, NJ | Hematology-Oncology | 15 | Under 11 | $104K |
| Ravi K Koti Ocala, FL | Hematology-Oncology | 21 | Under 11 | $101K |
| Vinicio Hernandez Orlando, FL | Medical Oncology | 18 | Under 11 | $101K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 13 | Under 11 | $101K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 1,848 | $9.6M |